News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US Panel Rejects Roche (RHHBY)'s Avastin for Breast Cancer



7/21/2010 6:48:07 AM

Reuters -- A U.S. panel dealt a blow to Roche Holding AG's (ROG.VX) multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. officials to revoke the medicine's approval for breast cancer after concluding studies showed insufficient benefit for patients.



comments powered by Disqus
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES